As you correctly surmised, ginge, I am a true cynic. And somewhat of a therapeutic nihilist.
My concern on this issue is that, faced with potential cost savings by encouraging widening use of statins, the boffins will tend to cherry-pick the statistics to support their agenda. That's why I am skeptical of our current love of meta-analysis. Mr. Dung quite accurately picked up on the deficiency in the mortality question.
And, as we've often pointed out, mortality still remains at 100%.